Literature DB >> 9360133

Method of noninvasive and continuous hemolysis/thrombogenesis measurement by laser photometry during artificial heart development.

Y Sankai1, T Tsutsui, T Jikuya, O Shigeta, M Ohta, T Mitsui.   

Abstract

The purpose of this research is to propose and develop a method to measure hemolysis and thrombogenesis non invasively and continuously to aid in development of an artificial heart. Generally, the optical absorption rate of hemoglobin is influenced by oxygen saturation except at the isosbestic point, which is not influenced by oxygen saturation. The authors, therefore, used an 805 nm laser diode, an optical spectrum analyzer to obtain greater accuracy. An experimental blood circuit system was constructed using a Bio-Pump, Tygon tubing, a soft shell reservoir, and an optical measurement system. Experimental settings for monitoring hemolysis were as follows; blood volume 200 ml, blood flow 6 L/min, and afterload 200 mmHg. Blood was sampled six times (0, 30, 60, 120, 180, and 240 min), and hemolysis in each sampled was measured using a colorimetric method. Comparing continuous laser measurement data with the sample data, an adequate correlation is obtained, proving that the dynamic trend of hemolysis could be continuously measured. Furthermore, to analyze the process of thrombogenesis, simple experiments were performed using blood neutralized by protamine. As a result, the authors could see the process of thrombogenesis as it occurred and could confirm that this method is able to dynamically detect hemolysis and thrombogenesis.

Entities:  

Mesh:

Year:  1997        PMID: 9360133

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  1 in total

1.  Development of a real-time and quantitative thrombus sensor for an extracorporeal centrifugal blood pump by near-infrared light.

Authors:  Daisuke Sakota; Tatsuki Fujiwara; Katsuhiro Ohuchi; Katsuyuki Kuwana; Hiroyuki Yamazaki; Ryo Kosaka; Masahiro Nishida; Tomohiro Mizuno; Hirokuni Arai; Osamu Maruyama
Journal:  Biomed Opt Express       Date:  2017-12-12       Impact factor: 3.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.